Search research articles
Contact Us
Filters
Showing results (171-180 of 287) with videos related to
Page
of 29
Sort By:
Clinical and Experimental Immunology
|
July 11, 2000
Neutrophil lactoferrin release induced by IgA immune complexes differed from that induced by cross-linking of fcalpha receptors (FcalphaR) with a monoclonal antibody, MIP8a
W Zhang, B Bi, R G Oldroyd, et al.
Journal of Medical Virology
|
June 26, 2001
Antibodies raised to short synthetic peptides with sequences derived from HIV-1 SF2 gp120 can both neutralize and enhance HIV-1 SF13: a later variant isolated from the same host
D Davis, H Trischmann, D M Stephens, et al.
Journal of Immunogenetics
|
August 1, 1978
Absence of variation in human C5
M A Vaz-Guedes, M J Hobart, P J Lachmann
Immunology
|
April 1, 1978
Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction
D M Scott, I McConnell, P Agomo, et al.
European Journal of Immunology
|
July 1, 1978
Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells
I McConnell, G Klein, T F Lint, et al.
The Journal of General Virology
|
December 1, 1990
Glycosylation governs the binding of antipeptide antibodies to regions of hypervariable amino acid sequence within recombinant gp120 of human immunodeficiency virus type 1
D Davis, D M Stephens, C Willers, et al.
European Journal of Immunology
|
October 1, 1972
The detection of theta antigen on cells by immunofluorescence: failure to detect theta antigen on rosette-forming cells
S M Russell, M Ferrarini, A Munro, et al.
The Journal of General Virology
|
December 1, 1993
Antisera raised against the second variable region of the external envelope glycoprotein of human immunodeficiency virus type 1 cross-neutralize and show an increased neutralization index when they act together with antisera to the V3 neutralization epitope
D Davis, D M Stephens, C A Carne, et al.
Structure (London, England : 1993)
|
March 15, 1994
Structure of a soluble, glycosylated form of the human complement regulatory protein CD59
C M Fletcher, R A Harrison, P J Lachmann, et al.
Clinical and Experimental Immunology
|
August 1, 1973
Deficiency of the second component of complement associated with anaphylactoid purpura and presence of mycoplasma in the serum
M Sussman, J H Jones, J D Almeida, et al.
Page
of 29
Search research articles
Search
Showing results (171-180 of 287) with videos related to
Sort By:
Page
of 29
Clinical and Experimental Immunology
|
July 11, 2000
Neutrophil lactoferrin release induced by IgA immune complexes differed from that induced by cross-linking of fcalpha receptors (FcalphaR) with a monoclonal antibody, MIP8a
W Zhang, B Bi, R G Oldroyd, et al.
Journal of Medical Virology
|
June 26, 2001
Antibodies raised to short synthetic peptides with sequences derived from HIV-1 SF2 gp120 can both neutralize and enhance HIV-1 SF13: a later variant isolated from the same host
D Davis, H Trischmann, D M Stephens, et al.
Journal of Immunogenetics
|
August 1, 1978
Absence of variation in human C5
M A Vaz-Guedes, M J Hobart, P J Lachmann
Immunology
|
April 1, 1978
Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction
D M Scott, I McConnell, P Agomo, et al.
European Journal of Immunology
|
July 1, 1978
Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells
I McConnell, G Klein, T F Lint, et al.
The Journal of General Virology
|
December 1, 1990
Glycosylation governs the binding of antipeptide antibodies to regions of hypervariable amino acid sequence within recombinant gp120 of human immunodeficiency virus type 1
D Davis, D M Stephens, C Willers, et al.
European Journal of Immunology
|
October 1, 1972
The detection of theta antigen on cells by immunofluorescence: failure to detect theta antigen on rosette-forming cells
S M Russell, M Ferrarini, A Munro, et al.
The Journal of General Virology
|
December 1, 1993
Antisera raised against the second variable region of the external envelope glycoprotein of human immunodeficiency virus type 1 cross-neutralize and show an increased neutralization index when they act together with antisera to the V3 neutralization epitope
D Davis, D M Stephens, C A Carne, et al.
Structure (London, England : 1993)
|
March 15, 1994
Structure of a soluble, glycosylated form of the human complement regulatory protein CD59
C M Fletcher, R A Harrison, P J Lachmann, et al.
Clinical and Experimental Immunology
|
August 1, 1973
Deficiency of the second component of complement associated with anaphylactoid purpura and presence of mycoplasma in the serum
M Sussman, J H Jones, J D Almeida, et al.
Page
of 29